Inogen Inc (NAS:INGN)
$ 8.43 0 (0%) Market Cap: 200.79 Mil Enterprise Value: 100.27 Mil PE Ratio: 0 PB Ratio: 1.08 GF Score: 79/100

Inogen Inc at JPMorgan Healthcare Conference Transcript

Jan 16, 2020 / 04:30PM GMT
Release Date Price: $51.79 (+1.81%)
K. Gong
JP Morgan Chase & Co, Research Division - Analyst

Okay. Welcome to the last day of the JPMorgan Healthcare Conference. My name is Allen Gong. I'm on the Medical Supplies and Devices team here at JPMorgan.

It's my pleasure today to introduce the President and CEO of Inogen, Scott Wilkinson; and the CFO, Ali Bauerlein. After the prepared remarks, the breakout session will be down the hall and then around the corner in the Olympic Room.

Scott Wilkinson
Inogen, Inc. - CEO, President & Director

Thank you. I'd like to begin as I usually do by just saying thank you to JPMorgan for inviting us to the 38th Annual Health Care Conference. It's always a pleasure to get up and speak with investors and tell our Inogen story. We're always thankful for that opportunity, and we're thankful for the opportunity today.

Our name, Inogen, stands for innovation in oxygen therapy. And I think you'll find as we go through the overview of our company and look at not only our product solutions but also our go-to-market strategy that, that name is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot